FDA Mulls Over Approval Of Controversial Alzheimer's Drug

The FDA is poised to decide whether to approve aducanumab, a drug to treat Alzheimer’s. It’s proved highly effective at removing the sticky amyloid plaques associated with the disease from the brain.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.